VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

NCT04725877 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV I Infection

Interventions

BIOLOGICAL: VIR-1111
DRUG: Placebo

Sponsor

Vir Biotechnology, Inc.

Collaborators

[object Object]